GroupID/ KindredID: 74CA, 2753NCI, 38CA
DiseaseAssertion: VHL
GroupSize: N/A
GroupNumberMales: N/A
GroupNumberFemales: N/A
GroupEthnicity: N/A
GroupAgeRange: N/A
GroupInfo: This germline familial VHL mutation was taken from the Cambridge, Department of Pathology database as well as the National Cancer Institute database with an unknown number of members belonging to Family ID 38CA, 74CA, 2753NCI. Table 3 lists all ID and mutations associated with individuals possessing renal carcinoma, without phechromocytoma.
GroupPresentingHPOs: HP:0005548 (renal cell carcinoma)
GroupHPOFreeText: Described as a VHL family with RCC, without pheochromocytoma. Other phenotypes are likely, however not detailed in this publication
GroupNotHPOs: HP:0002666 (pheochromocytoma)
GroupNotHPOFreeText: N/A
GroupPreviousTesting: N/A
PreviouslyPublished: 7728151; 9829911
SupplementalData: N/A
Variant: p.Q73* (c.217C>T)
LegacyVariant: p.Q73* (c.430C>T)
CaseProblemVariantFreeText: N/A
ClinVarID: 223164 https://www.ncbi.nlm.nih.gov/clinvar/variation/223164/
CAID: N/A
gnomAD: N/A
VariantEvidence: This paper declares this variant is predicted to compromise the Elongin-binding site by truncating the protein.
MutationType: stop_gained
CivicName: Q73* (c.217C>T)
MultipleGeneVariants: N/A